ScopeNorfolk & Norwich University Hospitals NHS Foundation Trust
233 capabilities
Verified Sep 2026
One of 2,380 in United Kingdom
Send one structured enquiry and we chase the reply for you. No cold email, no chasing.
Details
Norfolk and Waveney, Cellular Pathology Service, The Cotman Centre, Colney Lane
Norwich NR4 7UB , United Kingdom
Norwich NR4 7UB , United Kingdom
Accreditation
Active
UKAS
8405
nnuh.nhs.uk
Prefer to enquire through us? Send an enquiry
Accreditation Details
Accreditation Body
UKAS
Number
8405
Status
ActiveAccreditation is granted under EU Regulation 765/2008 and assessed against ISO/IEC 17025. Data sourced from official UKAS records.
Download Scope PDF
Test Capabilities (233)
| Standard Reference | Description | Category |
|---|---|---|
| Endocrine tissue | Insulin | Endocrine tissue | Insulin | Clinical Chemistry |
| Fibrinogen | Fibrinogen | Fibrinogen | Fibrinogen | Clinical Chemistry |
| Germ Cell Tumours | HCG | Germ Cell Tumours | HCG | Clinical Chemistry |
| Diferentiation of gram positive and | HIS.SS.P.12 & 13 | Diferentiation of gram positive and | HIS.SS.P.12 & 13 | Clinical Microbiology |
| Herpes Virus | Herpes virus | Herpes Virus | Herpes virus | Clinical Microbiology |
| Human Herpes Virus 8 / Kaposi’s | HHV8 | Human Herpes Virus 8 / Kaposi’s | HHV8 | Clinical Microbiology |
| JC / BK virus | SV-40 | JC / BK virus | SV-40 | Clinical Microbiology |
| Mycobacterium | M-Bovis | Mycobacterium | M-Bovis | Clinical Microbiology |
| Parvovirus | Parvovirus | Parvovirus | Parvovirus | Clinical Microbiology |
| Pneumocystis | PNC (PCP) | Pneumocystis | PNC (PCP) | Clinical Microbiology |
| Sarcoma | HLO (H.pylori) | Sarcoma | HLO (H.pylori) | Clinical Microbiology |
| Spirochetes | Spirochete | Spirochetes | Spirochete | Clinical Microbiology |
| Haemopoetic tissue | Giemsa | Haemopoetic tissue | Giemsa | Hematology |
| Haemopoetic tissue | HIS.SS.P.11 | Haemopoetic tissue | HIS.SS.P.11 | Hematology |
| Acid Mucins | Alcian Blue. | Acid Mucins | Alcian Blue. | Histopathology / Cytology |
| Adenocarcinoma Typing | CEA | Adenocarcinoma Typing | CEA | Histopathology / Cytology |
| Adenocarcinoma Typing | CK20, CK8/18 (CAM 5.2) | Adenocarcinoma Typing | CK20, CK8/18 (CAM 5.2) | Histopathology / Cytology |
| Adenocarcinoma Typing | GCDFP 15 | Adenocarcinoma Typing | GCDFP 15 | Histopathology / Cytology |
| Adenocarcinoma Typing | MUC-5AC | Adenocarcinoma Typing | MUC-5AC | Histopathology / Cytology |
| Adenocarcinoma Typing | Muc-1 | Adenocarcinoma Typing | Muc-1 | Histopathology / Cytology |
| Adenocarcinoma Typing | Muc-2 | Adenocarcinoma Typing | Muc-2 | Histopathology / Cytology |
| Adenocarcinoma typing | CK 7 | Adenocarcinoma typing | CK 7 | Histopathology / Cytology |
| Amyloid A | Amyloid A | Amyloid A | Amyloid A | Histopathology / Cytology |
| Amyloid | Alkaline | Amyloid | Alkaline | Histopathology / Cytology |
| Amyloid | HIS.SS.P.4 &31 | Amyloid | HIS.SS.P.4 &31 | Histopathology / Cytology |
| Asbestos Fibres | HIS.SS.P.28 | Asbestos Fibres | HIS.SS.P.28 | Histopathology / Cytology |
| Asbestos Fibres | Perls Stains | Asbestos Fibres | Perls Stains | Histopathology / Cytology |
| BRAF | SystemHIS.IM.P.21 Tumour | BRAF | SystemHIS.IM.P.21 Tumour | Histopathology / Cytology |
| Basal Cell Tumours | BER EP4 | Basal Cell Tumours | BER EP4 | Histopathology / Cytology |
| Basal Cells | 34 BE12 | Basal Cells | 34 BE12 | Histopathology / Cytology |
| Basal Cells/Carcinoma Invasion | CK 5 | Basal Cells/Carcinoma Invasion | CK 5 | Histopathology / Cytology |
| Basal Cells/Carcinoma Invasion | CK14 | Basal Cells/Carcinoma Invasion | CK14 | Histopathology / Cytology |
| Basal/Immature epithelium | CK17 | Basal/Immature epithelium | CK17 | Histopathology / Cytology |
| Basement Membrane | Laminin | Basement Membrane | Laminin | Histopathology / Cytology |
| Basement membranes | Collagen IV | Basement membranes | Collagen IV | Histopathology / Cytology |
| Basement membranes | HIS.SS.P.23 & 26 | Basement membranes | HIS.SS.P.23 & 26 | Histopathology / Cytology |
| Basement membranes | PA Silver | Basement membranes | PA Silver | Histopathology / Cytology |
| Brain Tumours | GFAP | Brain Tumours | GFAP | Histopathology / Cytology |
| Breast Tumour Her 2 status | Her 2 | Breast Tumour Her 2 status | Her 2 | Histopathology / Cytology |
| Breast/ Salivary Gland | Mammaglobin | Breast/ Salivary Gland | Mammaglobin | Histopathology / Cytology |
| Breast/Gynae Tumour Tamoxifen | ER | Breast/Gynae Tumour Tamoxifen | ER | Histopathology / Cytology |
| Calcified Tissue samples | HIS.CUT.P.09A | Calcified Tissue samples | HIS.CUT.P.09A | Histopathology / Cytology |
| Calcified Tissue samples | HIS.CUT.P.11 | Calcified Tissue samples | HIS.CUT.P.11 | Histopathology / Cytology |
| Calcium Salts | HIS.SS.P.39 | Calcium Salts | HIS.SS.P.39 | Histopathology / Cytology |
| Carcinoma | GATA-3 | Carcinoma | GATA-3 | Histopathology / Cytology |
| Clear cell carcinoma | HNF-1B | Clear cell carcinoma | HNF-1B | Histopathology / Cytology |
| Colorectal carcinoma | SAT B 2 | Colorectal carcinoma | SAT B 2 | Histopathology / Cytology |
| Connective Tissue | HIS.SS.P.38 | Connective Tissue | HIS.SS.P.38 | Histopathology / Cytology |
| Copper Associated Protein | HIS.SS.P.35 | Copper Associated Protein | HIS.SS.P.35 | Histopathology / Cytology |
| Cytomegalo Virus Infection | CMV | Cytomegalo Virus Infection | CMV | Histopathology / Cytology |
| Elastin | HIS.SS.P.8 | Elastin | HIS.SS.P.8 | Histopathology / Cytology |
| Endocrine Tissue | ACTH | Endocrine Tissue | ACTH | Histopathology / Cytology |
| Endocrine Tissue | Somatostatin | Endocrine Tissue | Somatostatin | Histopathology / Cytology |
| Endocrine Tumours | Glucagon | Endocrine Tumours | Glucagon | Histopathology / Cytology |
| Endocrine tissue | Calcitonin | Endocrine tissue | Calcitonin | Histopathology / Cytology |
| Endometrial hyperplasia | PAX2 | Endometrial hyperplasia | PAX2 | Histopathology / Cytology |
| Endometrial hyperplasia | PTEN | Endometrial hyperplasia | PTEN | Histopathology / Cytology |
| Endothelial Cells / GIST | CD34 | Endothelial Cells / GIST | CD34 | Histopathology / Cytology |
| Endothelial Cells | CD31 | Endothelial cells | CD31 | Histopathology / Cytology |
| Endothelial cells | FACTOR 8 | Endothelial cells | FACTOR 8 | Histopathology / Cytology |
| Endothelial/Mesothelium | Thrombomodulin | Endothelial/Mesothelium | Thrombomodulin | Histopathology / Cytology |
| Epstein Barr virus | EBER | Epstein Barr Virus | EBER | Histopathology / Cytology |
| Fibrin | HIS.SS.P.18 | Fibrin | HIS.SS.P.18 | Histopathology / Cytology |
| Fibrin | Martius Scarlet Blue | Fibrin | Martius Scarlet Blue | Histopathology / Cytology |
| Fibrohistocytic Tumour | Factor 13 | Fibrohistocytic Tumour | Factor 13 | Histopathology / Cytology |
| Fixed and fresh tissue, excisional Examination of tissues in order to | HIS.CUT.P.1& 7 | Fixed and fresh tissue, excisional Examination of tissues in order to | HIS.CUT.P.1& 7 | Histopathology / Cytology |
| Fixed and fresh tissue, excisional Examination of tissues in order to | HIS.LT.P.1&2 | Fixed and fresh tissue, excisional Examination of tissues in order to | HIS.LT.P.1&2 | Histopathology / Cytology |
| Fixed and fresh tissue, excisional | HIS.BD.P.1-6 | Fixed and fresh tissue, excisional | HIS.BD.P.1-6 | Histopathology / Cytology |
| Fixed and fresh tissue, excisional | HIS.BL.P.01 | Fixed and fresh tissue, excisional | HIS.BL.P.01 | Histopathology / Cytology |
| Fixed and fresh tissue, excisional | HIS.BL.P.02 | Fixed and fresh tissue, excisional | HIS.BL.P.02 | Histopathology / Cytology |
| Fixed and fresh tissue, excisional | HIS.MED.P.04 | Fixed and fresh tissue, excisional | HIS.MED.P.04 | Histopathology / Cytology |
| Fixed and fresh tissue, excisional | HIS.PR.P.02 | Fixed and fresh tissue, excisional | HIS.PR.P.02 | Histopathology / Cytology |
| Fixed and frozen tissue prepared as Visualisation of nuclear detail in | HIS.SL.P.1-2 | Fixed and frozen tissue prepared as Visualisation of nuclear detail in | HIS.SL.P.1-2 | Histopathology / Cytology |
| Fixed breast tissue HER 2 gene amplification | BOND | Fixed breast tissue HER 2 gene amplification | BOND | Histopathology / Cytology |
| Fixed breast tissue HER 2 gene amplification | Following in house procedure | Fixed breast tissue HER 2 gene amplification | Following in house procedure | Histopathology / Cytology |
| Fixed breast tissue HER 2 gene amplification | HIS.IM.P.14 based on | Fixed breast tissue HER 2 gene amplification | HIS.IM.P.14 based on | Histopathology / Cytology |
| Fixed tissue prepared as above Examination of tissues in order to | HIS.IM.P.01-15 | Fixed tissue prepared as above Examination of tissues in order to | HIS.IM.P.01-15 | Histopathology / Cytology |
| Fixed tissue prepared as above Examination of tissues in order to | HIS.IM.P.1-15 | Fixed tissue prepared as above Examination of tissues in order to | HIS.IM.P.1-15 | Histopathology / Cytology |
| Formalin Fixed paraffin processed Non-small cell lung cancer PD-L1 | PD-L1 (clone 22C3) | Formalin Fixed paraffin processed Non-small cell lung cancer PD-L1 | PD-L1 (clone 22C3) | Histopathology / Cytology |
| Fresh tissue, excisional and | , Cryostar NX70 | Fresh tissue, excisional and | , Cryostar NX70 | Histopathology / Cytology |
| Fresh tissue, excisional and | Cryostar NX70 | Fresh tissue, excisional and | Cryostar NX70 | Histopathology / Cytology |
| Fungi | HIS.SS.P.15 | Fungi | HIS.SS.P.15 | Histopathology / Cytology |
| Fungi | Microwave Grocott | Fungi | Microwave Grocott | Histopathology / Cytology |
| Fungi | PAS+D | Fungi | PAS+D | Histopathology / Cytology |
| GI Tract Tumours | CDX2 | GI Tract Tumours | CDX2 | Histopathology / Cytology |
| GIST | DOG-1 | GIST | DOG-1 | Histopathology / Cytology |
| Gastrointestinal Carcinomas | CA19.9 | Gastrointestinal Carcinomas | CA19.9 | Histopathology / Cytology |
| Germ Cell Tumours | OCT3/4 | Germ Cell Tumours | OCT3/4 | Histopathology / Cytology |
| Germ cell tumours | PLAP | Germ cell tumours | PLAP | Histopathology / Cytology |
| Gynae Carcinoma | Ca 125 | Gynae Carcinoma | Ca 125 | Histopathology / Cytology |
| Gynae Tumours | Inhibin | Gynae Tumours | Inhibin | Histopathology / Cytology |
| Haemosiderin pigment | HIS.SS.P.27 | Haemosiderin pigment | HIS.SS.P.27 | Histopathology / Cytology |
| Haemosiderin pigment | Perl’s Stain | Haemosiderin pigment | Perl’s Stain | Histopathology / Cytology |
| Hepatocellular Carcinoma | Arginase-1 | Hepatocellular Carcinoma | Arginase-1 | Histopathology / Cytology |
| Hepatocellular carcinoma | Glutamine Synthetase | Hepatocellular carcinoma | Glutamine Synthetase | Histopathology / Cytology |
| Hepatocytes (tumours) | Hepatocyte | Hepatocytes (tumours) | Hepatocyte | Histopathology / Cytology |
| Hydatidyform moles | P57 | Hydatidyform moles | P57 | Histopathology / Cytology |
| Lipid droplets | HIS.SS.P.22 | Lipid droplets | HIS.SS.P.22 | Histopathology / Cytology |
| Liposarcoma | MDM2 | Liposarcoma | MDM2 | Histopathology / Cytology |
| Lung / Thyroid Tumours | TTF1 | Lung / Thyroid Tumours | TTF1 | Histopathology / Cytology |
| Lung Adenocarcimoa | Napsin A | Lung Adenocarcimoa | Napsin A | Histopathology / Cytology |
| Lymphatics | D2 40 | Lymphatics | D2 40 | Histopathology / Cytology |
| Lymphoma / Plasma Cells | CD138 | Lymphoma / Plasma Cells | CD138 | Histopathology / Cytology |
| Lymphoma | C-Myc | Lymphoma | C-Myc | Histopathology / Cytology |
| Lymphoma | CD25 | Lymphoma | CD25 | Histopathology / Cytology |
| Lymphoma | Cyclin D1 | Lymphoma | Cyclin D1 | Histopathology / Cytology |
| Lymphoma | Glycophorin | Lymphoma | Glycophorin | Histopathology / Cytology |
| Lymphoma | Granzyme | Lymphoma | Granzyme | Histopathology / Cytology |
| Lymphoma | LCA (CD45) | Lymphoma | LCA (CD45) | Histopathology / Cytology |
| Lymphoma | MUM-1 | Lymphoma | MUM-1 | Histopathology / Cytology |
| Lymphoma | Myeloperoxidase | Lymphoma | Myeloperoxidase | Histopathology / Cytology |
| Lymphoma | TIA-1 | Lymphoma | TIA-1 | Histopathology / Cytology |
| Lymphoma | TdT | Lymphoma | TdT | Histopathology / Cytology |
| Lymphoma/Germ Cell Tumour | CD30 | Lymphoma/Germ Cell Tumour | CD30 | Histopathology / Cytology |
| Lymphoma/Mastocytosis | Mast Cell Tryptase | Lymphoma/Mastocytosis | Mast Cell Tryptase | Histopathology / Cytology |
| Lymphoma/Non-Small Cell Lung | ALK1 | Lymphoma/Non-Small Cell Lung | ALK1 | Histopathology / Cytology |
| Lymphoma/Renal Tumour | CD10, CD15 | Lymphoma/Renal Tumour | CD10, CD15 | Histopathology / Cytology |
| Malignant Mesothelioma | BAP 1 | Malignant Mesothelioma | BAP 1 | Histopathology / Cytology |
| Mast Cells /GIST | CD117 (C-KIT) | Mast Cells /GIST | CD117 (C-KIT) | Histopathology / Cytology |
| Melanin pigment | HIS.SS.P.19&34 | Melanin pigment | HIS.SS.P.19&34 | Histopathology / Cytology |
| Melanin pigment | Schmorl’s Ferricyanide | Melanin pigment | Schmorl’s Ferricyanide | Histopathology / Cytology |
| Melanoma BRAF Mutations | BRAF v600E | Melanoma BRAF Mutations | BRAF v600E | Histopathology / Cytology |
| Melanoma | HMB 45 | Melanoma | HMB 45 | Histopathology / Cytology |
| Melanoma | Melan A | Melanoma | Melan A | Histopathology / Cytology |
| Melanoma | PRAME | Melanoma | PRAME | Histopathology / Cytology |
| Melanoma/Salivary Gland Tumour | MITF | Melanoma/Salivary Gland Tumour | MITF | Histopathology / Cytology |
| Mesothelial cells | CALRETININ | Mesothelial cells | Calretinin | Histopathology / Cytology |
| Mesothelioma | SOX 10 | Mesothelioma | SOX 10 | Histopathology / Cytology |
| Mesothelioma/Ovarian Serous | WT-1 | Mesothelioma/Ovarian Serous | WT-1 | Histopathology / Cytology |
| Monocytes | CD68 | Monocytes | CD68 | Histopathology / Cytology |
| Monocytes | MAC 387 | Monocytes | MAC 387 | Histopathology / Cytology |
| Morphological assessment and | C.SP.P.547 Non-Gynae sample | Morphological assessment and | C.SP.P.547 Non-Gynae sample | Histopathology / Cytology |
| Morphological assessment and | LTO P2 Reports | Morphological assessment and | LTO P2 Reports | Histopathology / Cytology |
| Mucins | & 26 | Mucins | & 26 | Histopathology / Cytology |
| Mucins | AB PAS/+-D/Hales | Mucins | AB PAS/+-D/Hales | Histopathology / Cytology |
| Mucins | Mucicarmine HIS.SS.P.1,2,16,21,25 | Mucins | Mucicarmine HIS.SS.P.1,2,16,21,25 | Histopathology / Cytology |
| Muscle related intermediate | DESMIN | Muscle related intermediate | DESMIN | Histopathology / Cytology |
| Myocardial Infarction | Complement C9 | Myocardial Infarction | Complement C9 | Histopathology / Cytology |
| Myoepithelial Cells- Invasion | P63 | Myoepithelial Cells- Invasion | P63 | Histopathology / Cytology |
| Myogenic Tumour | MyoD | Myogenic Tumour | MyoD | Histopathology / Cytology |
| Myogenic Tumour | Myogenin | Myogenic Tumour | Myogenin | Histopathology / Cytology |
| Myogenic Tumour | Myoglobin | Myogenic Tumour | Myoglobin | Histopathology / Cytology |
| Myogenic Tumour | Myosin | Myogenic Tumour | Myosin | Histopathology / Cytology |
| NRAS | System | NRAS | System | Histopathology / Cytology |
| Neural Crest Tumour | NFP | Neural Crest Tumour | NFP | Histopathology / Cytology |
| Neural Crest derived cells/Tumours | S100 | Neural Crest derived cells/Tumours | S100 | Histopathology / Cytology |
| Neuroendocrine Cells | CEA | Neuroendocrine Cells | CEA | Histopathology / Cytology |
| Neuroendocrine Cells | Chromagranin A | Neuroendocrine Cells | Chromagranin A | Histopathology / Cytology |
| Neuroendocrine Cells | NSE | Neuroendocrine cells | NSE | Histopathology / Cytology |
| Neuroendocrine cells | Synaptophysin | Neuroendocrine cells | Synaptophysin | Histopathology / Cytology |
| Neuroendocrine/Lymphoma | CD56(N-cam) | Neuroendocrine/Lymphoma | CD56(N-cam) | Histopathology / Cytology |
| Non-serous fluids, Respiratory non-gynae cytological abnormalities | C.SP.P.553 Prep of a Clot | Non-serous fluids, Respiratory non-gynae cytological abnormalities | C.SP.P.553 Prep of a Clot | Histopathology / Cytology |
| Non-serous fluids, Respiratory non-gynae cytological abnormalities | C.SP.P.557 CSF and TSE/CJD | Non-serous fluids, Respiratory non-gynae cytological abnormalities | C.SP.P.557 CSF and TSE/CJD | Histopathology / Cytology |
| Non-serous fluids, Respiratory non-gynae cytological abnormalities | C.SP.P.563 Sentinel Node Imprints | Non-serous fluids, Respiratory non-gynae cytological abnormalities | C.SP.P.563 Sentinel Node Imprints | Histopathology / Cytology |
| Non-serous fluids, Respiratory non-gynae cytological abnormalities | C.SP.P.570 Serous Fluid | Non-serous fluids, Respiratory non-gynae cytological abnormalities | C.SP.P.570 Serous Fluid | Histopathology / Cytology |
| Non-serous fluids, Respiratory non-gynae cytological abnormalities | C.SP.P.571 Non-serous Fluid | Non-serous fluids, Respiratory non-gynae cytological abnormalities | C.SP.P.571 Non-serous Fluid | Histopathology / Cytology |
| Non-serous fluids, Respiratory non-gynae cytological abnormalities | C.SP.P.581 Use of the Centrifuge | Non-serous fluids, Respiratory non-gynae cytological abnormalities | C.SP.P.581 Use of the Centrifuge | Histopathology / Cytology |
| Non-serous fluids, Respiratory non-gynae cytological abnormalities | CP.HS.P.6005 | Non-serous fluids, Respiratory non-gynae cytological abnormalities | CP.HS.P.6005 | Histopathology / Cytology |
| Non-serous fluids, Respiratory non-gynae cytological abnormalities | Class 1 Safety cabinet | Non-serous fluids, Respiratory non-gynae cytological abnormalities | Class 1 Safety cabinet | Histopathology / Cytology |
| Pagets Disease | C-erb 2 | Pagets Disease | C-erb 2 | Histopathology / Cytology |
| Pan Cytokeratin | AE1/AE3 | Pan Cytokeratin | AE1/AE3 | Histopathology / Cytology |
| Pan Cytokeratin | CK(MNF116) | Pan Cytokeratin | CK(MNF116) | Histopathology / Cytology |
| Parathyroid | Parathyroid | Parathyroid | Parathyroid | Histopathology / Cytology |
| Proliferation Marker | Ki-67 (MIB-1) | Proliferation Marker | Ki-67 (MIB-1) | Histopathology / Cytology |
| Prostate Tumour | PSA | Prostate Tumour | PSA | Histopathology / Cytology |
| Prostate adenocarcinoma | NKX3.1 | Prostate adenocarcinoma | NKX3.1 | Histopathology / Cytology |
| Prostate cancer | CK5 / AMACR (double) | Prostate cancer | CK5 / AMACR (double) | Histopathology / Cytology |
| Prostate grading | AMACR (Racemase) | Prostate grading | AMACR (Racemase) | Histopathology / Cytology |
| Renal /Ovarian Serous | PAX 8 | Renal /Ovarian Serous | PAX 8 | Histopathology / Cytology |
| Renal Transplant rejection | C4 d | Renal Transplant rejection | C4 d | Histopathology / Cytology |
| Renal Tumour | RCC | Renal Tumour | RCC | Histopathology / Cytology |
| Renal cell carcinoma | Carbonic Anhydrase IX (CA9) | Renal cell carcinoma | Carbonic Anhydrase IX (CA9) | Histopathology / Cytology |
| Reticulin Fibres | CopperHIS.SS.P.32 | Reticulin Fibres | CopperHIS.SS.P.32 | Histopathology / Cytology |
| Salivary Gland Tumour | Androgen | Salivary Gland Tumour | Androgen | Histopathology / Cytology |
| Sarcoma Typing | CDK4 | Sarcoma Typing | CDK4 | Histopathology / Cytology |
| Sarcoma | ERG | Sarcoma | ERG | Histopathology / Cytology |
| Sarcoma | MUC 4 | Sarcoma | MUC 4 | Histopathology / Cytology |
| Sarcoma | Vimentin | Sarcoma | Vimentin | Histopathology / Cytology |
| Sarcoma/Genital Tract Tumour | CD99 | Sarcoma/Genital Tract Tumour | CD99 | Histopathology / Cytology |
| Slides prepared as above Morphological assessment and | HIS.MED.P.02 Consultant | Slides prepared as above Morphological assessment and | HIS.MED.P.02 Consultant | Histopathology / Cytology |
| Slides prepared as above Morphological assessment and | HIS.MED.P.09 Histopathology | Slides prepared as above Morphological assessment and | HIS.MED.P.09 Histopathology | Histopathology / Cytology |
| Slides prepared as above Morphological assessment and | HIS.MED.P.10 Histopathology | Slides prepared as above Morphological assessment and | HIS.MED.P.10 Histopathology | Histopathology / Cytology |
| Slides prepared as above Morphological assessment and | HIS.MED.P.11 Histopathology | Slides prepared as above Morphological assessment and | HIS.MED.P.11 Histopathology | Histopathology / Cytology |
| Slides prepared as above Morphological assessment and | HIS.MED.P.12 Histopathology | Slides prepared as above Morphological assessment and | HIS.MED.P.12 Histopathology | Histopathology / Cytology |
| Slides prepared as above Morphological assessment and | HIS.MED.P.13 Histopathology | Slides prepared as above Morphological assessment and | HIS.MED.P.13 Histopathology | Histopathology / Cytology |
| Slides prepared as above Morphological assessment and | HIS.MED.P.14 Histopathology | Slides prepared as above Morphological assessment and | HIS.MED.P.14 Histopathology | Histopathology / Cytology |
| Slides prepared as above Morphological assessment and | HIS.MED.P.15 Histopathology | Slides prepared as above Morphological assessment and | HIS.MED.P.15 Histopathology | Histopathology / Cytology |
| Slides prepared as above Morphological assessment and | HIS.MED.P.16 Histopathology | Slides prepared as above Morphological assessment and | HIS.MED.P.16 Histopathology | Histopathology / Cytology |
| Slides prepared as above Morphological assessment and | HIS.MED.P.17 Histopathology | Slides prepared as above Morphological assessment and | HIS.MED.P.17 Histopathology | Histopathology / Cytology |
| Slides prepared as above Morphological assessment and | HIS.MED.P.18 Histopathology | Slides prepared as above Morphological assessment and | HIS.MED.P.18 Histopathology | Histopathology / Cytology |
| Slides prepared as above Morphological assessment and | HIS.MED.P.19 Histopathology | Slides prepared as above Morphological assessment and | HIS.MED.P.19 Histopathology | Histopathology / Cytology |
| Solitary Fibrous Tumours | STAT6 | Solitary Fibrous Tumours | STAT6 | Histopathology / Cytology |
| Squamous Cell Carcinoma | P 40 | Squamous Cell Carcinoma | P 40 | Histopathology / Cytology |
| Synovial Sarcoma | TLE1 | Synovial Sarcoma | TLE1 | Histopathology / Cytology |
| Thyroid Tumour | Thyroglobulin | Thyroid Tumour | Thyroglobulin | Histopathology / Cytology |
| Translocation renal cell carcinomas | TFE3 | Translocation renal cell carcinomas | TFE3 | Histopathology / Cytology |
| Tumour Grading (Gynae Upper GI) | P53 | Tumour Grading (Gynae Upper GI) | P53 | Histopathology / Cytology |
| Tumour grading | IMP 3 | Tumour grading | IMP 3 | Histopathology / Cytology |
| Upper GI Lesions | P53 / IMP3 (double) | Upper GI Lesions | P53 / IMP3 (double) | Histopathology / Cytology |
| and IHC tests. | (P100021F1601) slide scanners | and IHC tests. | (P100021F1601) slide scanners | Histopathology / Cytology |
| and IHC tests. | 3D HISTECH P1000 | and IHC tests. | 3D HISTECH P1000 | Histopathology / Cytology |
| and IHC tests. | HIS.DIG.P.02 use of scanning | and IHC tests. | HIS.DIG.P.02 use of scanning | Histopathology / Cytology |
| and IHC tests. | Leica Aperio GT450 (45253) | and IHC tests. | Leica Aperio GT450 (45253) | Histopathology / Cytology |
| Auto immune disease | IgG4 | Auto immune disease | IgG4 | Immunology / Serology |
| Detection of: | Gemini ELISA platform LP-MIC-SOP | Detection of : | Manual Indirect | Immunology / Serology |
| Epstein Barr virus | EBV | Epstein Barr virus | EBV | Immunology / Serology |
| Lymphoma/Renal Disease | IgG | Lymphoma/Renal Disease | IgG | Immunology / Serology |
| Breast Tumour (Tamoxifen | PR | Breast Tumour (Tamoxifen | PR | Other |
| Cervical/vaginal cells (Liquid Based Preparation and screening to | Use of ThinPrep T5000, Prisma | Cervical/vaginal cells (Liquid Based Preparation and screening to | Use of ThinPrep T5000, Prisma | Other |
| Cytology/LBC sample) Papilloma Viral (HR HPV) DNA | C.H.P.1001 – Testing for HR-HPV | Cytology/LBC sample) Papilloma Viral (HR HPV) DNA | C.H.P.1001 – Testing for HR-HPV | Other |
| Cytology/LBC sample) identify or exclude gynae- | C.SR.P.405 – Rejection of Samples | Cytology/LBC sample) identify or exclude gynae- | C.SR.P.405 – Rejection of Samples | Other |
| Cytology/LBC sample) identify or exclude gynae- | C.SR.P.407 – Checking & Labelling | Cytology/LBC sample) identify or exclude gynae- | C.SR.P.407 – Checking & Labelling | Other |
| Cytology/LBC sample) identify or exclude gynae- | C.SR.P.408 – Minimum Standards | Cytology/LBC sample) identify or exclude gynae- | C.SR.P.408 – Minimum Standards | Other |
| Cytology/LBC sample) identify or exclude gynae- | C.SR.P.415 – Operation of the | Cytology/LBC sample) identify or exclude gynae- | C.SR.P.415 – Operation of the | Other |
| Cytology/LBC sample) identify or exclude gynae- | C.SR.P.421 – Operation of the | Cytology/LBC sample) identify or exclude gynae- | C.SR.P.421 – Operation of the | Other |
| Cytology/LBC sample) identify or exclude gynae- | C.SR.P.424 – Papanicolaou | Cytology/LBC sample) identify or exclude gynae- | C.SR.P.424 – Papanicolaou | Other |
| Cytology/LBC sample) identify or exclude gynae- | Cytyc ThinPrep 5000 | Cytology/LBC sample) identify or exclude gynae- | Cytyc ThinPrep 5000 | Other |
| Cytology/LBC sample) interpretation/diagnosis | C.SC.P.801 – Primary Screening of | Cytology/LBC sample) interpretation/diagnosis | C.SC.P.801 – Primary Screening of | Other |
| Cytology/LBC sample) interpretation/diagnosis | C.SC.P.805 – Computer (LabTrak) | Cytology/LBC sample) interpretation/diagnosis | C.SC.P.805 – Computer (LabTrak) | Other |
| Cytology/LBC sample) interpretation/diagnosis | C.SC.P.806 – Standardised | Cytology/LBC sample) interpretation/diagnosis | C.SC.P.806 – Standardised | Other |
| Cytology/LBC sample) interpretation/diagnosis | Reporting | Cytology/LBC sample) interpretation/diagnosis | Reporting | Other |
| Fine needle aspirates, Blood, Examination to identify or exclude | C.SP.P.591 Staining Protocols for | Fine needle aspirates, Blood, Examination to identify or exclude | C.SP.P.591 Staining Protocols for | Other |
| Fixed and frozen tissue prepared as Visualisation of nuclear detail in | Leica Autostainer 5020 with | Fixed and frozen tissue prepared as Visualisation of nuclear detail in | Leica Autostainer 5020 with | Other |
| Fixed breast tissue HER 2 gene amplification | Leica HER2 FISH System for | Fixed breast tissue HER 2 gene amplification | Leica HER2 FISH System for | Other |
| Glycogen (and other PAS +ve | HIS.SS.P.25 & 26 | Glycogen (and other PAS +ve | HIS.SS.P.25 & 26 | Other |
| HNPCC | MSI Markers (MSH2, MSH6, MLH1 | HNPCC | MSI Markers (MSH2, MSH6, MLH1 | Other |
| Non-serous fluids, Respiratory non-gynae cytological abnormalities | C.SP.P.532 Preparation of | Non-serous fluids, Respiratory non-gynae cytological abnormalities | C.SP.P.532 Preparation of | Other |
| Non-serous fluids, Respiratory non-gynae cytological abnormalities | C.SP.P.555 Preparation of | Non-serous fluids, Respiratory non-gynae cytological abnormalities | C.SP.P.555 Preparation of | Other |
| Non-serous fluids, Respiratory non-gynae cytological abnormalities | C.SP.P.556 Samples received in | Non-serous fluids, Respiratory non-gynae cytological abnormalities | C.SP.P.556 Samples received in | Other |
| Non-serous fluids, Respiratory non-gynae cytological abnormalities | C.SP.P.566 Urine and | Non-serous fluids, Respiratory non-gynae cytological abnormalities | C.SP.P.566 Urine and | Other |
| Norfolk & Norwich University Hospitals | Norfolk & Norwich University Hospitals | Other |
| Slides prepared as above Morphological assessment and | HIS.MED.P.01 Guidelines for | Slides prepared as above Morphological assessment and | HIS.MED.P.01 Guidelines for | Other |
| Tumour Grading (Gynae, Head & | P16 | Tumour Grading (Gynae, Head & | P16 | Other |
Send an Enquiry
Request a quote, ask about capacity, or discuss your testing requirements directly with this lab.